Has Raoul Joubran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,656 in general payments to Raoul Joubran, MD across 248 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raoul Joubran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raoul Joubran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raoul Joubran, MD

Gastroenterology · Casper, WYNPI 1689784373

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2022 at $972 and has fallen 52.2% since, to $465 in 2025.

$4,656in general payments, 2019–2025

Across 248 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Takeda Pharmaceuticals U.S.A., Inc.$1K
Gilead$344
Sanofi$337
Regeneron Healthcare Solutions, Inc.$279
Pfizer$191
plus $807 from 16 others

What the payments were for

Food & beverage$4,52597%
Education$241%
Gifts$1072%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	94	$1,539
Takeda Pharmaceuticals U.S.A., Inc.	67	$1,160
Gilead	20	$344
Sanofi	8	$337
Regeneron Healthcare Solutions, Inc.	13	$279
Pfizer	9	$191
Braintree Laboratories, Inc.	3	$121
Johnson & Johnson	6	$111
Intercept Pharmaceuticals, Inc.	7	$109
Actelion Pharmaceuticals US, Inc.	1	$87
Merck	4	$79
Aimmune Therapeutics, Inc.	3	$55
Mauna Kea Technologies, Inc.	2	$51
Phathom Pharmaceuticals, Inc.	2	$35
Bristol Myers Squibb	2	$29
Lilly USA, LLC	1	$29
UCB, Inc.	1	$26
Alfasigma USA, Inc.	1	$20
Nestle Healthcare Nutrition Inc.	1	$16
Novo Nordisk	1	$14
Daiichi Sankyo Inc.	1	$12
QOL Medical, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$103

How this compares

Too few gastroenterology providers in Wyomingto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$282,805

Medicare patients

1,111

Services billed

2,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	441	$5,211
Lubiprostone	21	$4,307
Omeprazole	190	$2,706
Mesalamine	13	$1,969
Famotidine	156	$1,927
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	14	$933
Sucralfate	11	$507
Esomeprazole Magnesium	16	$392
Hydrocortisone	16	$335
Procto-Med HcHydrocortisone	20	$330
Dicyclomine Hcl	16	$175

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Casper

Chad CooperCasper$5K
Phillip KrmpotichCasper$5K
Jeffrey CloudCasper$3K
William ShearCasper$3K
Kent KatzCasper$2K
Luis ArmstrongCasper$2K
Jamie SkroveCheyenne$5K
Scott McRaeCheyenne$2K
Charles KuckelCheyenne$440
Kenneth KranzCheyenne$355

See the full list for Wyoming →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →